Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 36415 | 81 | 35.6 | 81% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
| 693 | 3 | VANADIUM//VANADIUM COMPLEXES//VANADATE | 7226 |
| 3552 | 2 | TUNGSTATE COMPLEXES//VACCINE NANOTECHNOL//CHIM PHYS SOLUT CNRS URA 434 | 1349 |
| 36415 | 1 | VACCINE NANOTECHNOL//NANOPARTICULATE VACCINE//WHOLE CELL LYSATE | 81 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | VACCINE NANOTECHNOL | address | 2193354 | 10% | 73% | 8 |
| 2 | NANOPARTICULATE VACCINE | authKW | 502643 | 2% | 67% | 2 |
| 3 | WHOLE CELL LYSATE | authKW | 484690 | 4% | 43% | 3 |
| 4 | ALPHA SECRETASE SIGNALING | authKW | 376984 | 1% | 100% | 1 |
| 5 | ANTIOXIDANT CATALASE | authKW | 376984 | 1% | 100% | 1 |
| 6 | ANTISENSE NF KAPPA B | authKW | 376984 | 1% | 100% | 1 |
| 7 | ANTISENSE OLIGOMERS TO NF KAPPA B | authKW | 376984 | 1% | 100% | 1 |
| 8 | ANTISENSE OLIGONUCLEOTIDES TO NF KAPPA B | authKW | 376984 | 1% | 100% | 1 |
| 9 | BACILLI CALMETTE GUERIN BCG | authKW | 376984 | 1% | 100% | 1 |
| 10 | BIONANOCOMPOSITE COATINGS | authKW | 376984 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Chemistry, Applied | 490 | 23% | 0% | 19 |
| 2 | Pharmacology & Pharmacy | 410 | 42% | 0% | 34 |
| 3 | Immunology | 197 | 25% | 0% | 20 |
| 4 | Engineering, Chemical | 124 | 17% | 0% | 14 |
| 5 | Polymer Science | 74 | 12% | 0% | 10 |
| 6 | Materials Science, Biomaterials | 66 | 5% | 0% | 4 |
| 7 | Medicine, Research & Experimental | 46 | 10% | 0% | 8 |
| 8 | Chemistry, Medicinal | 42 | 7% | 0% | 6 |
| 9 | Biochemistry & Molecular Biology | 35 | 21% | 0% | 17 |
| 10 | Cell Biology | 27 | 11% | 0% | 9 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | VACCINE NANOTECHNOL | 2193354 | 10% | 73% | 8 |
| 2 | EMORY CHILDRENS CYST FIBROSIS PEDIAT | 376984 | 1% | 100% | 1 |
| 3 | SO PHAR | 376984 | 1% | 100% | 1 |
| 4 | PHARM HLTH SCI | 217886 | 33% | 2% | 27 |
| 5 | SO PHARM | 160615 | 9% | 6% | 7 |
| 6 | NSUH | 125660 | 1% | 33% | 1 |
| 7 | GRP BIOQUIM OXIDANTES ANTIOXIDANTES | 41885 | 1% | 11% | 1 |
| 8 | LITWIN ZUCKER STUDY ALZHEIMERS DIS MEMO | 37697 | 1% | 10% | 1 |
| 9 | BERNARD J DUNN PHARM | 33587 | 4% | 3% | 3 |
| 10 | MED SURG HLTH SCI | 30294 | 6% | 2% | 5 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | JOURNAL OF MICROENCAPSULATION | 41228 | 17% | 1% | 14 |
| 2 | JOURNAL OF DRUG TARGETING | 24255 | 12% | 1% | 10 |
| 3 | JOURNAL OF INTERFERON AND CYTOKINE RESEARCH | 4190 | 6% | 0% | 5 |
| 4 | MOLECULAR MEDICINE | 2189 | 4% | 0% | 3 |
| 5 | FONTES ARTIS MUSICAE | 1704 | 1% | 0% | 1 |
| 6 | LYMPHOKINE AND CYTOKINE RESEARCH | 1602 | 1% | 0% | 1 |
| 7 | ADVANCES IN NATURAL SCIENCES-NANOSCIENCE AND NANOTECHNOLOGY | 1202 | 1% | 0% | 1 |
| 8 | DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY | 1115 | 5% | 0% | 4 |
| 9 | BIOMACROMOLECULES | 894 | 5% | 0% | 4 |
| 10 | JOURNAL OF ENDOTOXIN RESEARCH | 682 | 1% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | OETTINGER, CW , D'SOUZA, MJ , (2010) SYNERGISM IN SURVIVAL TO ENDOTOXIC SHOCK IN RATS GIVEN MICROENCAPSULATED CNI-1493 AND ANTISENSE OLIGOMERS TO NF-KAPPA B.JOURNAL OF MICROENCAPSULATION. VOL. 27. ISSUE 4. P. 372 -376 | 10 | 77% | 5 |
| 2 | OETTINGER, CW , D'SOUZA, MJ , (2012) MICROENCAPSULATED DRUG DELIVERY: A NEW APPROACH TO PRO-INFLAMMATORY CYTOKINE INHIBITION.JOURNAL OF MICROENCAPSULATION. VOL. 29. ISSUE 5. P. 455-462 | 15 | 47% | 3 |
| 3 | UDDIN, MN , PATEL, NJ , BHOWMIK, T , D'SOUZA, B , AKALKOTKAR, A , ETZLAR, F , OETTINGER, CW , D'SOUZA, M , (2013) ENHANCED BIOAVAILABILITY OF ORALLY ADMINISTERED ANTISENSE OLIGONUCLEOTIDE TO NUCLEAR FACTOR KAPPA B MRNA AFTER MICROENCAPSULATION WITH ALBUMIN.JOURNAL OF DRUG TARGETING. VOL. 21. ISSUE 5. P. 450 -457 | 13 | 38% | 3 |
| 4 | UDDIN, MN , SIDDIQ, A , OETTINGER, CW , D'SOUZA, MJ , (2011) POTENTIATION OF PRO-INFLAMMATORY CYTOKINE SUPPRESSION AND SURVIVAL BY MICROENCAPSULATED DEXAMETHASONE IN THE TREATMENT OF EXPERIMENTAL SEPSIS.JOURNAL OF DRUG TARGETING. VOL. 19. ISSUE 9. P. 752 -760 | 12 | 38% | 2 |
| 5 | WANG, J , GRISHIN, AV , FORD, HR , (2016) EXPERIMENTAL ANTI-INFLAMMATORY DRUG SEMAPIMOD INHIBITS TLR SIGNALING BY TARGETING THE TLR CHAPERONE GP96.JOURNAL OF IMMUNOLOGY. VOL. 196. ISSUE 12. P. 5130 -5137 | 12 | 19% | 1 |
| 6 | AKALKOTKAR, A , CHABLANI, L , TAWDE, SA , D'SOUZA, C , D'SOUZA, MJ , (2015) DEVELOPMENT OF A MICROPARTICULATE PROSTATE CANCER VACCINE AND EVALUATING THE EFFECT OF ROUTE OF ADMINISTRATION ON ITS EFFICACY VIA THE SKIN.JOURNAL OF MICROENCAPSULATION. VOL. 32. ISSUE 3. P. 281 -289 | 8 | 29% | 0 |
| 7 | SIWALE, R , MEADOWS, F , MODY, VV , SHAH, S , (2013) FORMULATION AND DRUG-CONTENT ASSAY OF MICROENCAPSULATED ANTISENSE OLIGONUCLEOTIDE TO NF-KAPPA B USING ATR-FTIR.ADVANCES IN NATURAL SCIENCES-NANOSCIENCE AND NANOTECHNOLOGY. VOL. 4. ISSUE 3. P. - | 6 | 38% | 0 |
| 8 | TAWDE, SA , CHABLANI, L , AKALKOTKAR, A , D'SOUZA, MJ , (2016) EVALUATION OF MICROPARTICULATE OVARIAN CANCER VACCINE VIA TRANSDERMAL ROUTE OF DELIVERY.JOURNAL OF CONTROLLED RELEASE. VOL. 235. ISSUE . P. 147 -154 | 8 | 23% | 1 |
| 9 | SIWALE, RC , OETTINGER, CW , ADDO, R , SIDDIG, A , D'SOUZA, MJ , (2009) THE EFFECT OF INTRACELLULAR DELIVERY OF CATALASE AND ANTISENSE OLIGONUCLEOTIDES TO NF-KAPPA B USING ALBUMIN MICROCAPSULES IN THE ENDOTOXIC SHOCK MODEL.JOURNAL OF DRUG TARGETING. VOL. 17. ISSUE 9. P. 701 -709 | 7 | 30% | 3 |
| 10 | SANKOWSKI, R , HERRING, A , KEYVANI, K , FRENZEL, K , WU, JY , ROSKAM, S , NOELKER, C , BACHER, M , AL-ABED, Y , (2016) THE MULTI-TARGET EFFECTS OF CNI-1493: CONVERGENCE OF ANTIAMYLODOGENIC AND ANTIINFLAMMATORY PROPERTIES IN ANIMAL MODELS OF ALZHEIMER'S DISEASE.MOLECULAR MEDICINE. VOL. 22. ISSUE . P. 776 -788 | 9 | 20% | 0 |
Classes with closest relation at Level 1 |